Dara Petel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dara Petel has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Aaron Campigotto
Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada, M5G 1×8; Division of Microbiology, The Hospital for Sick Children (SickKids), 555 University Avenue, Toronto, ON, Canada, M5G 1×8; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, Canada, M5S 3K3
3 shared publicationsJames Wright
Public Health Ontario, 661 University Avenue, Toronto, ON, Canada, M5G 1M1
3 shared publicationsIan Kitai
Division des maladies infectieuses, département de pédiatrie, The Hospital for Sick Children, Université de Toronto, Toronto, Ont
2 shared publicationsMichelle Science
Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada
2 shared publications- Michelle Science
Infection Prevention and Control, Hospital for Sick Children, Toronto, Ontario, Canada
2 shared publications Mohsin Ali
Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
2 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by Elsevier in Journal of Infection
- Vol. 92 (3) , 106701
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, Canada
- 13 February 2026
- Published by Elsevier in Journal of Infection
- Vol. 92 (3) , 106701
Open AccessAssessing measles immunity in individuals of childbearing age in Toronto, Ontario, Canada
- 21 May 2025
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 30 (6) , 486-492
Antibiotic prescribing practices for acute otitis media and community-acquired pneumonia in a pediatric emergency department
Background: Recent evidence-based pediatric guidelines recommend a 5-day course of amoxicillin as first-line therapy for uncomplicated acute otitis media (AOM) in children 2 years and older and community-acquired pneumonia (CAP). The objective of this study was to assess the guideline consistency of antibiotic prescriptions for AOM and CAP in a Canadian quaternary care pediatric emergency department (ED) and identify opportunities to improve antibiotic prescribing. Methods: We retrospectively reviewed antibiotic prescriptions for patients 0 to 18 years old discharged from the ED with a diagnosis of AOM or CAP from September 2022 through September 2023. Clinical information and prescription data were extracted from the electronic medical record. Analysis was completed using descriptive statistics. Results: Of 2313 retrieved records, 1143 (85%) cases of AOM and 753 (75%) cases of CAP met the inclusion criteria. Six hundred and eighty-eight (60%) AOM prescriptions and 140 (19%) CAP prescriptions were guideline-consistent. Prescriptions were not guideline-consistent largely because of antibiotic duration (62% for AOM—67% attributable to excess duration; 93% for CAP— > 99% attributable to excess duration), followed by antibiotic dosing interval (31% for AOM; 22% for CAP), antibiotic selection (17% for AOM; 6% for CAP) and antibiotic dose (8% for AOM; 2% for CAP). Of 293 patients eligible for deferred prescriptions for AOM based on age and clinical presentation, only 52% received them. Conclusions: Most guideline-discordant prescriptions for both AOM and CAP resulted from prolonged antibiotic duration. Given the frequency of these diagnoses, effective interventions to improve guideline consistency would have a significant impact at a population level.
- 21 May 2025
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 30 (6) , 486-492
Antibiotic prescribing practices for acute otitis media and community-acquired pneumonia in a pediatric emergency department
Background: Recent evidence-based pediatric guidelines recommend a 5-day course of amoxicillin as first-line therapy for uncomplicated acute otitis media (AOM) in children 2 years and older and community-acquired pneumonia (CAP). The objective of this study was to assess the guideline consistency of antibiotic prescriptions for AOM and CAP in a Canadian quaternary care pediatric emergency department (ED) and identify opportunities to improve antibiotic prescribing. Methods: We retrospectively reviewed antibiotic prescriptions for patients 0 to 18 years old discharged from the ED with a diagnosis of AOM or CAP from September 2022 through September 2023. Clinical information and prescription data were extracted from the electronic medical record. Analysis was completed using descriptive statistics. Results: Of 2313 retrieved records, 1143 (85%) cases of AOM and 753 (75%) cases of CAP met the inclusion criteria. Six hundred and eighty-eight (60%) AOM prescriptions and 140 (19%) CAP prescriptions were guideline-consistent. Prescriptions were not guideline-consistent largely because of antibiotic duration (62% for AOM—67% attributable to excess duration; 93% for CAP— > 99% attributable to excess duration), followed by antibiotic dosing interval (31% for AOM; 22% for CAP), antibiotic selection (17% for AOM; 6% for CAP) and antibiotic dose (8% for AOM; 2% for CAP). Of 293 patients eligible for deferred prescriptions for AOM based on age and clinical presentation, only 52% received them. Conclusions: Most guideline-discordant prescriptions for both AOM and CAP resulted from prolonged antibiotic duration. Given the frequency of these diagnoses, effective interventions to improve guideline consistency would have a significant impact at a population level.
- 10 December 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (4) , e122-e123
Bartonella quintana Endocarditis Associated With Head Lice in a Canadian Indigenous Youth
Bartonella quintana is a rare but important cause of culture-negative endocarditis, classically associated with body lice infestation. We report the first known pediatric case of Bartonella quintana endocarditis associated with head lice. The importance of sending targeted testing for this organism in at-risk patients, ideally on tissue specimens, is emphasized.
- 10 December 2024
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (4) , e122-e123
Bartonella quintana Endocarditis Associated With Head Lice in a Canadian Indigenous Youth
Bartonella quintana is a rare but important cause of culture-negative endocarditis, classically associated with body lice infestation. We report the first known pediatric case of Bartonella quintana endocarditis associated with head lice. The importance of sending targeted testing for this organism in at-risk patients, ideally on tissue specimens, is emphasized.
- Open Access
- 7 November 2024
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (1) , 102-104
Empiric antibiotic prescribing practices for gram-positive coverage of late-onset sepsis in neonatal intensive care units in North America
Late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) causes significant morbidity and mortality, yet guidance on empiric management is limited. We surveyed NICUs across Canada and the United States regarding their empiric antimicrobial regimens for LOS, thereby identifying large practice variations and high rates of empiric vancomycin use.
- 7 November 2024
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (1) , 102-104
Open AccessEmpiric antibiotic prescribing practices for gram-positive coverage of late-onset sepsis in neonatal intensive care units in North America
Late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) causes significant morbidity and mortality, yet guidance on empiric management is limited. We surveyed NICUs across Canada and the United States regarding their empiric antimicrobial regimens for LOS, thereby identifying large practice variations and high rates of empiric vancomycin use.
- 25 October 2024
- Published by University of Toronto Press Inc. (UTPress) in Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Vol. 9 (3) , 183-187
Vaccine-associated measles in an immunocompromised host: Hospital infection prevention and control and public health response
Introduction: Vaccine-associated measles is generally not considered to be transmissible, as opposed to wild-type measles, which is one of the most highly contagious diseases. Data on contact and exposure management of vaccine-associated measles is limited, with varied approaches to such cases described in the literature. Methods: We report the case of a 2-year-old immunosuppressed child who developed a febrile exanthem with mild conjunctivitis 18 days after receiving the measles-mumps-rubella-varicella vaccine. Results: Given the patient's recent measles-containing vaccination while on immunosuppressive medications, consistent clinical findings, and the lack of epidemiological risk factors for wild-type infection the decision was made to treat this as a presumptive case of vaccine-associated measles virus prior to return of confirmatory genotyping results. After consultation with public health experts, contact tracing was not considered necessary. No secondary measles cases were identified, despite a large exposure potential due to lack of consistent airborne precautions during hospital admission. Discussion: This case highlights the lack of transmissibility of vaccine-associated measles in immunocompromised hosts, adding to the scant body of literature on this topic, with the potential to inform hospital infection prevention and control as well as public health management in similar situations.
- 25 October 2024
- Published by University of Toronto Press Inc. (UTPress) in Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Vol. 9 (3) , 183-187
Vaccine-associated measles in an immunocompromised host: Hospital infection prevention and control and public health response
Introduction: Vaccine-associated measles is generally not considered to be transmissible, as opposed to wild-type measles, which is one of the most highly contagious diseases. Data on contact and exposure management of vaccine-associated measles is limited, with varied approaches to such cases described in the literature. Methods: We report the case of a 2-year-old immunosuppressed child who developed a febrile exanthem with mild conjunctivitis 18 days after receiving the measles-mumps-rubella-varicella vaccine. Results: Given the patient's recent measles-containing vaccination while on immunosuppressive medications, consistent clinical findings, and the lack of epidemiological risk factors for wild-type infection the decision was made to treat this as a presumptive case of vaccine-associated measles virus prior to return of confirmatory genotyping results. After consultation with public health experts, contact tracing was not considered necessary. No secondary measles cases were identified, despite a large exposure potential due to lack of consistent airborne precautions during hospital admission. Discussion: This case highlights the lack of transmissibility of vaccine-associated measles in immunocompromised hosts, adding to the scant body of literature on this topic, with the potential to inform hospital infection prevention and control as well as public health management in similar situations.
- 4 October 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (12) , e31365
Burden of SARS‐CoV‐2 infection prior to vaccine eligibility among immunocompromised children aged 1–11 years at a pediatric tertiary referral hospital in Toronto, Canada
SARS‐CoV‐2 seroprevalence reflects the efficacy of pandemic infection prevention and control measures. We performed anti‐spike IgG serological testing on residual sera of children 1–11 years old at a tertiary care referral center between October and November 2021. Immunocompromised patients had the highest SARS‐CoV‐2 seroprevalence, at 40.5%, compared to 19.3% in non‐immunocompromised patients. Targeted infection prevention and public health interventions are warranted for pediatric immunocompromised patients in future pandemics.
- 4 October 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (12) , e31365
Burden of SARS‐CoV‐2 infection prior to vaccine eligibility among immunocompromised children aged 1–11 years at a pediatric tertiary referral hospital in Toronto, Canada
SARS‐CoV‐2 seroprevalence reflects the efficacy of pandemic infection prevention and control measures. We performed anti‐spike IgG serological testing on residual sera of children 1–11 years old at a tertiary care referral center between October and November 2021. Immunocompromised patients had the highest SARS‐CoV‐2 seroprevalence, at 40.5%, compared to 19.3% in non‐immunocompromised patients. Targeted infection prevention and public health interventions are warranted for pediatric immunocompromised patients in future pandemics.
- Open Access
- 29 October 2023
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 195 (42) , E1459-E1460
Infection àMycobacterium bovisdisséminée se manifestant par une adénite cervicale chez une jeune fille de 15 ans
- 29 October 2023
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 195 (42) , E1459-E1460
Open AccessInfection àMycobacterium bovisdisséminée se manifestant par une adénite cervicale chez une jeune fille de 15 ans
- Open Access
- 4 September 2023
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 195 (34) , E1155-E1156
DisseminatedMycobacterium bovisinfection presenting with cervical lymphadenitis in a 15-year-old girl
A 15-year-old, previously healthy, Syrian-born girl, who had immigrated from Turkey 3 months previously, presented to the emergency department with a 6-month history of cervical swelling, weight loss and intermittent fevers; a 1-month history of cough; and acute onset of night sweats.
- 4 September 2023
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 195 (34) , E1155-E1156
Open AccessDisseminatedMycobacterium bovisinfection presenting with cervical lymphadenitis in a 15-year-old girl
A 15-year-old, previously healthy, Syrian-born girl, who had immigrated from Turkey 3 months previously, presented to the emergency department with a 6-month history of cervical swelling, weight loss and intermittent fevers; a 1-month history of cough; and acute onset of night sweats.